Cardiovascular action of a cardioselective Ca 2+ channel blocker AH-1058 in conscious dogs assessed by telemetry

By Takahara A.   Dohmoto H.   Yoshimoto R.   Sugiyama A.   Hashimoto K.  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite

Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models

By Arita J.   Yi X.X.   Nu N.A.   Fukuyama K.   Wakui Y.   Niitsu K.   Maruno M.   Chen S.   Hashimoto K.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 333-340

Elsevier

Access to resources Recommend Favorite

Effects of azimilide, a K V(r) and K V(s) blocker, on canine ventricular arrhythmia models

By Xue Y.   Yamada C.   Chino D.   Hashimoto K.  

European Journal of Pharmacology, Vol. 376, Iss. 1, 1999-07 ,pp. : 27-35

Elsevier

Access to resources Recommend Favorite

Effects of CP-060S, a novel Ca 2+ channel blocker, on oxidative stress in cultured cardiac myocytes

By Hara A.   Suzuki T.   Hashizume H.   Shishido N.   Nakamura M.   Ushikubi F.   Abiko Y.  

European Journal of Pharmacology, Vol. 385, Iss. 1, 1999-11 ,pp. : 81-88

Elsevier

Access to resources Recommend Favorite

T-477, a novel Ca 2+ - and Na + channel blocker, prevents veratridine-induced neuronal injury

By Okuyama K.   Kiuchi S.   Okamoto M.   Narita H.   Kudo Y.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite